首页> 美国卫生研究院文献>Infection and Immunity >Development of a Single-Gene Signature-Tag-Based Approach in Combination with Alanine Mutagenesis To Identify Listeriolysin O Residues Critical for the In Vivo Survival of Listeria monocytogenes
【2h】

Development of a Single-Gene Signature-Tag-Based Approach in Combination with Alanine Mutagenesis To Identify Listeriolysin O Residues Critical for the In Vivo Survival of Listeria monocytogenes

机译:单基因基于签名标签的方法与丙氨酸诱变相结合以确定李斯特菌单核细胞增生李斯特菌的体内存活至关重要的李斯特菌溶血素O残留的发展。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Listeriolysin O (LLO) is a pore-forming toxin of the cholesterol-dependent cytolysin (CDC) family and a primary virulence factor of the intracellular pathogen Listeria monocytogenes. LLO mediates rupture of phagosomal membranes, thereby releasing bacteria into the growth-permissive host cell cytosol. Several unique features of LLO allow its activity to be precisely regulated in order to facilitate phagosomal escape, intracellular growth, and cell-to-cell spread. To improve our understanding of the multifaceted contribution of LLO to the pathogenesis of L. monocytogenes, we developed a screen that combined saturation mutagenesis and signature tags, termed in vivo analysis by saturation mutagenesis and signature tags (IVASS). We generated a library of LLO mutant strains, each harboring a single amino acid substitution and a signature tag, by using the previously described pPL2 integration vector. The signature tags acted as molecular barcodes, enabling high-throughput, parallel analysis of 40 mutants in a single animal and identification of attenuated mutants by negative selection. Using the IVASS technique we were able to screen over 90% of the 505 amino acids present in LLO and identified 60 attenuated mutants. Of these, 39 LLO residues were previously uncharacterized and potentially revealed novel functions of the toxin during infection. The mutants that were subsequently analyzed in vivo each conferred a 2- to 4-orders of magnitude loss in virulence compared to wild type, thereby validating the screening methods. Phenotypic analysis of the LLO mutant library using common in vitro techniques suggested that the functional contributions of some residues could only have been revealed through in vivo analysis.
机译:李斯特菌溶血素O(LLO)是胆固醇依赖性溶血素(CDC)家族的成孔毒素,是细胞内病原体单核细胞增生李斯特菌的主要致病因子。 LLO介导吞噬体膜的破裂,从而将细菌释放到允许生长的宿主细胞胞质溶胶中。 LLO的几个独特功能允许精确调节其活性,以促进吞噬体逃逸,细胞内生长和细胞间扩散。为了增进我们对LLO对单核细胞增生李斯特氏菌发病机理的多方面贡献的理解,我们开发了一种结合了饱和诱变和签名标签的屏幕,称为通过饱和诱变和签名标签(IVASS)进行体内分析。通过使用先前描述的pPL2整合载体,我们生成了一个LLO突变菌株的文库,每个菌株都具有一个氨基酸取代和一个标记标签。签名标签充当分子条形码,可对单个动物中的40个突变体进行高通量并行分析,并通过阴性选择鉴定减毒突变体。使用IVASS技术,我们能够筛选LLO中存在的505个氨基酸中的90%以上,并鉴定出60个减毒突变体。其中,39个LLO残基以前未被鉴定,在感染过程中可能揭示了毒素的新功能。与野生型相比,随后在体内进行分析的突变体各自赋予2至4个数量级的毒力损失,从而验证了筛选方法。使用常见的体外技术对LLO突变体文库进行表型分析表明,某些残基的功能性贡献只能通过体内分析来揭示。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号